Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma.

MLA

Hu, Bei, et al. “Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-Cell Lymphoma.” Transplantation and Cellular Therapy, vol. 30, no. 11, Nov. 2024, p. 1082.e1-1082.e10. EBSCOhost, https://doi.org/10.1016/j.jtct.2024.09.007.

APA

Hu, B., Vaidya, R., Ahmed, F., Ehsan, H., Moyo, T. K., Jacobs, R. W., Pang, Y., Park, S., Wallander, M. L., Shroff, V., Boseman, V., Beam, T., Elder, J., Yountz, M., Jennings, R. D., Howard, D. S., Avalos, B., Copelan, E. A., Mesa, R., & Ghosh, N. (2024). Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma. Transplantation and Cellular Therapy, 30(11), 1082.e1-1082.e10. https://doi.org/10.1016/j.jtct.2024.09.007

Chicago

Hu, Bei, Rakhee Vaidya, Ferdous Ahmed, Hamid Ehsan, Tamara K Moyo, Ryan W Jacobs, Yifan Pang, et al. 2024. “Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-Cell Lymphoma.” Transplantation and Cellular Therapy 30 (11): 1082.e1-1082.e10. doi:10.1016/j.jtct.2024.09.007.